Alec van Gelder: From Crisis Care to Continuous Care in SCD
Alec van Gelder, Vice President of Corporate Affairs, Rare Disease at Novo Nordisk, shared a post on LinkedIn:
“This World Sickle Cell Day, Friday 19th June, Novo Nordisk is honored to be part of the global conversation around sickle cell disease (SCD).
Join us on June 19th, 2026 at 11am EST for a Virtual 24-Hour Sickle Cell Awareness and Action Event, in collaboration with the Global Alliance of Sickle Cell Disease Organizations, Alliance of Sickle Cell Disease Organisations (GASCDO), focused on: ‘Closing the Survival Gap in Sickle Cell Disease: From Crisis Care to Chronic, Continuous Care’.
Dr. Ify Osunkwo, Director of Patient Advocacy – Hemoglobinopathies, will be moderating this incredible panel alongside our partners and distinguished global experts. This event is a testament to our commitment to patients living with sickle cell disease worldwide.
Register here: (Dr. Osunkwo’s session begins at 11am EST / 5pm CEST)
Let’s stand together, raise awareness, and drive meaningful change for the sickle cell community!”
Stay updated with Hemostasis Today.
-
Aug 7, 2026, 16:26Shayan Mohammadmoradi: Excited to Co-Chair the 2028 Hemostasis Gordon Research Seminar
-
Aug 7, 2026, 16:04Ayuka King-Percival: Understanding Platelet Aggregation Testing
-
Aug 7, 2026, 15:59Nita Radhakrishnan։ New Evidence-Based Guidelines for Transfusion-Dependent Thalassemia
-
Aug 7, 2026, 15:54Seema Dawood: Why the Peripheral Blood Smear Still Matters in the Age of Automation?
-
Aug 7, 2026, 15:42Mohammed Elmourtada Abdulgayoom։ Caplacizumab-Enabled Treatment of iTTP Without Plasma Exchange
-
Aug 7, 2026, 15:40Renata Evertz: THUNDER Study Sets a New Benchmark in Stroke Thrombectomy
-
Aug 7, 2026, 15:23Ashley Brown: An Incredible Week at the Hemostasis GRC
-
Aug 7, 2026, 15:04Danique Steeghs: Developing a Chip-Sized ADAMTS13 Activity Assay for TTP Point-of-Care Testing
-
Aug 7, 2026, 15:02Mohd Laraib: The Importance of Multidisciplinary Collaboration in the Management of CAPS